CCIZX | ISTIX | CCIZX / ISTIX | |
Total Expense Ratio | 0.93 | 0.91 | 102% |
Annual Report Gross Expense Ratio | 0.93 | 0.91 | 102% |
Fund Existence | 15 years | 18 years | - |
Gain YTD | 19.104 | 24.086 | 79% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 16.3B | 6.44B | 253% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 22.16 | 21.61 | 103% |
Returns for 3 years | 64.85 | 43.21 | 150% |
Returns for 5 years | 75.01 | -7.88 | -953% |
Returns for 10 years | 191.45 | 54.43 | 352% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HELX | 30.62 | 0.36 | +1.20% |
Franklin Genomic Advancements ETF | |||
GMOM | 31.20 | 0.26 | +0.83% |
Cambria Global Momentum ETF | |||
IBDU | 23.49 | 0.04 | +0.17% |
iShares iBonds Dec 2029 Term Corp ETF | |||
PYT | 23.03 | N/A | N/A |
Merrill Lynch Depositor PPLUS Floating Rate Call TR Cert Ser GSC-2(Goldman Sachs) | |||
SIXA | 49.59 | -0.17 | -0.35% |
ETC 6 Meridian Mega Cap Equity ETF |